Latest Breaking News On - பிரான்ஸ் பிரஞ்சு தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் - Page 1 : comparemela.com

(1) Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat difficult to treat/resistant hypertension and heart failure, announces the publication in Biomedecine &Pharmacotherapy of a new scientific peer-reviewed article reporting the efficacy of firibastat in combination with enalapril and hydrochlorothiazide in an experimental model of salt-sensitive hypertension (the DOCA-salt hypertensive rat). The article, entitled Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats is available online on the website of the journal Biomedecine -& Pharmacotherapy (Biomedicine & Pharmacotherapy - Journal - Elsevier DOI: 10.1016/j.biopha.2021.111682). The reported data demonstrate that the hypotensive effect induced in hypertensive DOCA-salt rat with a once-daily treatment

New yorkUnited statesFrance generalCatherine llorens cortesFabrice balavoineMike tattoryFrance french national institute of healthDevelopment of quantum genomicsScientific centre for national researchDescartes universityQuantum genomicsEuronext growthVice president researchParis descartes universityFrench national instituteMedical research